Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 7c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• China e-commerce sees 3% growth in July, recovery expected Macquarie says